Opioid-maker Mallinckrodt’s bankruptcy will cut nearly $1 billion from settlement
Drug manufacturer Mallinckrodt Pharmaceuticals plans to file for bankruptcy, seeking to pay nearly $1 billion less to a trust as part of a settlement over its role in the opioid crisis.